Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155916 | SCV000205627 | likely benign | not specified | 2013-07-17 | criteria provided, single submitter | clinical testing | Phe69Phe in Exon 1 of GIPC3: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and it is not located w ithin the splice consensus sequence. |
Gene |
RCV001711424 | SCV001942488 | benign | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001711424 | SCV002426754 | benign | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004757966 | SCV005353926 | benign | GIPC3-related disorder | 2024-09-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |